About Us

In 2013, Steve and Jeff assembled the very first RX1 prototype with parts commissioned from a local machine shop. They sat in Steve’s rec room anxiously waiting for the epoxy to set and secure the shaft so they could see how their design performed. After what seemed like an eternity, the glue had set. They took the putter, adjusted the weight and lie angle and started rolling putts. They were astonished at the results - incredible stability and control, great feel, very consistent and great sound too - they immediately knew that they had created something special.

Excitement grew as they began showing the putter to friends as well as professional golfers, and the response was overwhelmingly positive. Soon, they traveled up to TPC where they presented the RX1 putter to Deane Beman, former PGA TOUR Commissioner. At first glance, Deane’s eyes lit up and said, “I know what you’ve got there - that’s a lie adjustable, High MOI putter!” Deane eagerly rolled a few putts, watching one drop after another and said, “This is the most technologically advanced putter ever made. I want to be involved.”

Needless to say, Steve and Jeff were beyond ecstatic to receive such a compliment from Deane Beman, a man who was not only had a tremendous career as a professional golfer, but had also played such a significant role in the success and growth of the sport during his 20 years serving as PGA TOUR Commissioner. Not only did Mr. Beman love the putter and the science behind it, but he wanted to be involved!

Cure assembled a diverse team, set up manufacturing and fulfillment procedures and then went on to launch the RX1 & RX2 at the 2014 PGA Merchandise show in Orlando, FL. The response was overwhelming, with players, pros, and celebrities crowding the booth to get a putter fitting and check out these unique new putters! During the show, Cure Putters were featured on Golf Channel's Morning Drive and the PGA SHOW SPOTLIGHT listed Cure Putters #1 on their list of new products!

In June of 2014, Jim Barfield, former Co-Founder of Rife Putters left the company he helped build to join Cure Team as VP of Professional Tours. 

In July 2014, new shaft and color options were introduced and the momentum continued to build as the Cure RX Series Putters gained traction in the market. Everyone from high handicappers to Tour players were seeing remarkable improvements in their putting. R&D continued and several new models began to take shape.

In 2015, Cure introduced 5 new models, the RX1 Tour and RX2 Tour which are essentially smaller profile versions of the original, High MOI, center shafted RX1 and RX2. The RX3, a High MOI, heel shafted, tri-sole putter with a smaller profile and full adjustability. The RX3F has the addition of a rear flange. And last but certainly not least, the RXi, a High MOI blade style putter with a more traditional look and feel, featuring interchangeable face inserts and adjustable weight.

Throughout 2015, Cure continued to experience explosive growth, with nearly 600 domestic retail accounts and distribution in 6 countries. Cure Putters became the Fastest Growing Putter on the Champions Tour and also had a growing number of LPGA players each week.

In 2016 Cure introduced 6 new models, starting with the Cure Classic Series, a High MOI blade putter. Very traditional in style, just slightly oversized with large tungsten weight inserts in the heel and toe, creating the most aggressive weight ratio of any blade putter in history. The Classic Series CX1 and CX2 are square back and round back blades respectively with incredible stability and forgiveness that rivals the leading High MOI mallets.

The RX Series evolved in 2016 with 4 new models, a redesigned RX3 and brand new RX4, RX5 and RX6. Building on the success of the previous models, the New RX Series putters were refined with a more streamlined look at address and a precision milled face for a softer feel and drastically improved sound.

Cure continued to see success on tour throughout 2016 with a growing number of players on the PGA Tour, LPGA Tour, PGA Tour Champions, and PGA Tour LatinoAmerica for a total of 60 players putting a Cure in play, capturing 3 wins and 22 Top-10s.

In 2017, Cure expanded the Classic Series line with the addition of the CX3 mallet. The RX Series, CX1 and CX2 returned with subtile enhancements to the head shape, new alignment and shaft options. Later in the year, Cure launched the CX4 mallet and introduced an anodized red finish option.

Jerry Kelly began using a CX1 in the 2nd round of the 3M Championship and went on to win his next tournament, the Boeing Classic with the CX1 in his bag. Kelly went on to capture another win a few weeks later at the Pacific Links Bear Mountain Championship. Kelly played the CX1 throughout 2017 for 2 wins and 6 Top-10s and set a Tour record of 14 consecutive rounds in the 60s. Kelly was named the PGA Tour Champions 2017 Rookie of the Year.

In 2018, Cure launched the Tour X Series, which was designed with feedback from our Tour Players and features a slightly smaller head with a sleeker, lower profile, multi-metal design with High MOI and wide range of adjustable weighting. Cure also introduced the Hybrid X Series which combines the finest aspects of Cure engineering, featuring an adjustable lie angle with interchangeable shafts, a multi-metal design with a light weight aluminum head, stainless steel inserts in the heel and toe, and removable steel weights for adjustability.